HC Wainwright & Co. Reiterates Buy on Alimera Sciences, Maintains $5 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Alimera Sciences (NASDAQ:ALIM) and maintained a $5 price target.
May 25, 2023 | 1:37 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alimera Sciences receives a reiterated Buy rating from HC Wainwright & Co. analyst Yi Chen, with a maintained $5 price target.
The reiterated Buy rating and maintained $5 price target by HC Wainwright & Co. analyst Yi Chen indicates a positive outlook for Alimera Sciences. This news is likely to have a positive impact on the stock price in the short term as it reaffirms the analyst's confidence in the company's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100